The impact of chronic hepatitis C on resource utilisation and in-patient mortality for Medicare beneficiaries between 2005 and 2010

被引:29
|
作者
Younossi, Z. M. [1 ,2 ]
Stepanova, M. [2 ]
Mishra, A. [1 ]
Venkatesan, C. [1 ]
Henry, L. [2 ]
Hunt, S. [1 ,2 ]
机构
[1] Inova Fairfax Hosp, Dept Med, Falls Church, VA USA
[2] Inova Hlth Syst, Betty & Guy Beatty Ctr Integrated Res, Falls Church, VA USA
关键词
QUALITY-OF-LIFE; DUAL ELIGIBLES; COST; EPIDEMIOLOGY; VIRUS;
D O I
10.1111/apt.12485
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BackgroundAs baby boomers age, chronic hepatitis C (CHC) will become increasingly important in Medicare eligible group. AimTo evaluate trends in Medicare resource utilisation for CHC. MethodsWe analysed the Medicare in-patient and out-patient data from 2005 to 2010. For each patient, all claims with CHC as a principal diagnosis were added up and yearly CHC-related spending was calculated. ResultsA total of 48880 out-patient claims for 21655 CHC patients and 4884 hospital admission claims for 3092 patients were included. The number of in-patient (1.5-1.6/year) or out-patient (2.2-2.3/year) visits per patient did not change over time, nor did the demographic characteristics of the CHC population. The majority of this population was eligible for Medicare based on disability and the average number of diagnoses per in-patient claim (from 8.11 in 2005 to 8.60 in 2010) and per out-patient claim (from 2.18 in 2005 to 2.71 in 2010) increased (both P<0.0001). The average total yearly spending per patient increased in the out-patient setting from $488 in 2005 to $584 in 2010 (P=0.0132) and did not change in the in-patient setting (from $22245 in 2005 to $23383 in 2010, P=0.14). In the multivariate analysis, the number of diagnoses and conditions per claim and the number of in-patient or out-patient procedures per year were the important independent predictors of increased resource utilisation. ConclusionsMost Medicare beneficiaries with chronic hepatitis C who sought in-patient or out-patient care in 2005-2010 had received Medicare for disability. Although the total resource utilisation did not change, the proportion of patient's responsibility increased.
引用
收藏
页码:1065 / 1075
页数:11
相关论文
共 50 条
  • [1] The Impact of Chronic Hepatitis C (CH-C) on the Inpatient Resource Utilization and Mortality for Medicare Beneficiaries Between 2005 to 2010
    Stepanova, Maria
    Mishra, Alita
    Trimble, Gregory
    Venkatesan, Chapy
    Nader, Fatema
    Younossi, Zobair M.
    [J]. GASTROENTEROLOGY, 2013, 144 (05) : S448 - S448
  • [2] Trend in the Outpatients Resource Utilizations Among Medicare Beneficiaries With Chronic Hepatitis C: From 2005 to 2010
    Mishra, Alita
    Stepanova, Maria
    Kalwaney, Shirley
    Venkatesan, Chapy
    Afendy, Mariam
    Younossi, Zobair M.
    [J]. GASTROENTEROLOGY, 2013, 144 (05) : S1017 - S1017
  • [3] CHARACTERISTICS OF MEDICARE BENEFICIARIES WITH CHRONIC HEPATITIS C VIRUS
    Scaife, J.
    Kuti, E.
    Acampa, L.
    Million, R.
    Miyasato, G.
    Wang, Z.
    Sander, S.
    Sanchez, H.
    Kokkotos, F. K.
    [J]. VALUE IN HEALTH, 2013, 16 (03) : A82 - A82
  • [4] Presence of hepatitis C (HCV) infection in Baby Boomers with Medicare is independently associated with mortality and resource utilisation
    Sayiner, M.
    Wymer, M.
    Golabi, P.
    Ford, J.
    Srishord, I.
    Younossi, Z. M.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 43 (10) : 1060 - 1068
  • [5] PREVALENCE OF MEDICARE BENEFICIARIES WITH A RECENT DIAGNOSIS OF CHRONIC HEPATITIS C IN 2016
    Ballreich, J.
    Levin, J.
    [J]. VALUE IN HEALTH, 2019, 22 : S204 - S204
  • [6] Disparities in the quality of care for chronic hepatitis C among Medicare beneficiaries
    Linh Tran
    Jung, Jeah
    Feldman, Roger
    Riley, Thomas, III
    [J]. PLOS ONE, 2022, 17 (03):
  • [7] Prevalence, mortality and healthcare utilization among Medicare beneficiaries with Hepatitis C in Haemodialysis units
    Deshpande, Rati
    Stepanova, Maria
    Golabi, Pegah
    Brown, Kimberly
    Younossi, Zobair M.
    [J]. JOURNAL OF VIRAL HEPATITIS, 2019, 26 (11) : 1293 - 1300
  • [8] Hospice care in Medicare patients with primary liver cancer: the impact on resource utilisation and mortality
    Fukui, N.
    Golabi, P.
    Otgonsuren, M.
    de Avila, L.
    Bush, H.
    Younossi, Z. M.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 47 (05) : 680 - 688
  • [9] PREVALENCE OF HEPATIC OUTCOMES AMONG MEDICARE BENEFICIARIES DIAGNOSED WITH CHRONIC HEPATITIS C VIRUS
    Scaife, J.
    Kuti, E.
    Acampa, L.
    Million, R.
    Miyasato, G.
    Wang, Z.
    Sander, S.
    Sanchez, H.
    Kokkotos, F. K.
    [J]. VALUE IN HEALTH, 2013, 16 (03) : A82 - A82
  • [10] Association of Direct-Acting Antiviral Treatment With Mortality Among Medicare Beneficiaries With Hepatitis C
    Kalidindi, Yamini
    Jung, Jeah
    Feldman, Roger
    Riley, Thomas
    [J]. JAMA NETWORK OPEN, 2020, 3 (07)